A Fascination with Chromosome Rescue in Uniparental Disomy: Mendelian Recessive Outlaws and Imprinting Copyrights Infringements
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Monosomy X Turner Syndrome Information for Patients
Monosomy X Turner syndrome Information for patients The healthcare professional responsible for your care has given you this leaflet because you have been identified by the Harmony® Prenatal Test as having a high probability of a chromosome disorder in your pregnancy. This fact sheet contains more information about the particular genetic disorder mentioned in your Harmony report. We recommend that you also discuss your result with an experienced doctor or genetic counsellor. Turner syndrome, or Monosomy X, is a sex chromosome disorder that occurs in females when there is only one copy of the X chromosome instead of the expected two (Figure 1). It occurs in at least one in every 2,500 female births. Monosomy X may be associated with an increased risk of miscarriage in the first or second trimester. More than half of those withT urner syndrome will be mosaic, meaning some of their cells have just one X chromosome and the other cells have two X chromosomes. Features and symptoms of Turner syndrome include subtle changes in physical appearance, short stature, infertility and learning difficulties, as well as some potential health conditions, including cardiac conditions, hypothyroidism, diabetes and autoimmune disease. Babies who are born with Turner syndrome could have a number of the features and symptoms of the syndrome, however, not everyone will have them all and severity will vary significantly. Mosaicism also plays a role in the varied severity of the syndrome. Although there is no cure for Turner syndrome, many of the associated symptoms can be treated. Girls with Turner syndrome may need regular health checks of their heart, kidneys and reproductive system throughout their lives. -
Fine–Mapping Identifies NAD–ME1 As a Candidate Underlying a Major
bioRxiv preprint doi: https://doi.org/10.1101/2020.09.07.285429; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Fine–mapping identifies NAD–ME1 as a candidate underlying 2 a major locus controlling temporal variation in primary and 3 specialized metabolism in Arabidopsis 4 5 Marta Francisco1, Daniel J. Kliebenstein2,3, Víctor M. Rodríguez1, Pilar Soengas1, 6 Rosaura Abilleira1, María E. Cartea1 7 1Misión Biológica de Galicia, (MBG-CSIC), P.O. Box 28, 36080, Pontevedra, Spain 8 2Department of Plant Sciences, University of California at Davis, Davis, CA 95616, 9 USA. 10 3DynaMo Center of Excellence, University of Copenhagen, Thorvaldsensvej 40, DK- 11 1871 Frederiksberg C, Denmark. 12 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.07.285429; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 13 Summary 14 Plant metabolism is modulated by a complex interplay between internal signals and 15 external cues. A major goal of all quantitative metabolomic studies is to clone the 16 underlying genes to understand the mechanistic basis of this variation. Using fine-scale 17 genetic mapping, in this work we report the identification and initial characterization of 18 NAD-DEPENDENT MALIC ENZYME 1 (NAD-ME1) as the candidate gene underlying 19 the pleiotropic network Met.II.15 QTL controlling variation in plant metabolism and 20 circadian clock outputs in the Bay × Sha Arabidopsis population. -
Chromosome 18
Chromosome 18 Description Humans normally have 46 chromosomes in each cell, divided into 23 pairs. Two copies of chromosome 18, one copy inherited from each parent, form one of the pairs. Chromosome 18 spans about 78 million DNA building blocks (base pairs) and represents approximately 2.5 percent of the total DNA in cells. Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. Chromosome 18 likely contains 200 to 300 genes that provide instructions for making proteins. These proteins perform a variety of different roles in the body. Health Conditions Related to Chromosomal Changes The following chromosomal conditions are associated with changes in the structure or number of copies of chromosome 18. Distal 18q deletion syndrome Distal 18q deletion syndrome occurs when a piece of the long (q) arm of chromosome 18 is missing. The term "distal" means that the missing piece (deletion) occurs near one end of the chromosome arm. The signs and symptoms of distal 18q deletion syndrome include delayed development and learning disabilities, short stature, weak muscle tone ( hypotonia), foot abnormalities, and a wide variety of other features. The deletion that causes distal 18q deletion syndrome can occur anywhere between a region called 18q21 and the end of the chromosome. The size of the deletion varies among affected individuals. The signs and symptoms of distal 18q deletion syndrome are thought to be related to the loss of multiple genes from this part of the long arm of chromosome 18. -
Robertsonian Translocations FTNW
Robertsonian Translocations rarechromo.org Robertsonian translocations A Robertsonian translocation is an unusual type of chromosome rearrangement caused by two particular chromosomes joining together. Out of every 1,000 newborn babies, one has a Robertsonian translocation. The phrase Robertsonian translocation is too long for normal conversation and many people shorten it to rob . When the translocation is balanced , the person with it is called a Robertsonian translocation carrier . As carriers are healthy and have a normal lifespan, many never discover about their unusual chromosome rearrangement. In fact, the translocation can be passed down in families for many generations without anyone discovering. An unbalanced Robertsonian translocation may come to light after a baby is born with a chromosome disorder. Most babies with unbalanced Robertsonian translocations have parents with normal chromosomes. A minority of babies have one parent who is a Robertsonian translocation carrier. What are chromosomes? Chromosomes are the microscopically small structures in the nucleus of the body’s cells that carry genes. These genes are the instructions that tell our bodies how to develop and work properly. We have 46 chromosomes in all, 23 inherited from our father and 23 from our mother. Each chromosome has a short arm and a long arm. Five of the 23 chromosomes have a very small short arm that contains no unique genes; these are chromosome 13, 14, 15, 21 and 22. Technically, they are called acrocentric chromosomes. In a Robertsonian translocation, two of the five acrocentric chromosomes have . broken at the beginning of the short arm near the point where it meets the long arm. -
Sema4 Noninvasive Prenatal Select
Sema4 Noninvasive Prenatal Select Noninvasive prenatal testing with targeted genome counting 2 Autosomal trisomies 5 Trisomy 21 (Down syndrome) 6 Trisomy 18 (Edwards syndrome) 7 Trisomy 13 (Patau syndrome) 8 Trisomy 16 9 Trisomy 22 9 Trisomy 15 10 Sex chromosome aneuploidies 12 Monosomy X (Turner syndrome) 13 XXX (Trisomy X) 14 XXY (Klinefelter syndrome) 14 XYY 15 Microdeletions 17 22q11.2 deletion 18 1p36 deletion 20 4p16 deletion (Wolf-Hirschhorn syndrome) 20 5p15 deletion (Cri-du-chat syndrome) 22 15q11.2-q13 deletion (Angelman syndrome) 22 15q11.2-q13 deletion (Prader-Willi syndrome) 24 11q23 deletion (Jacobsen Syndrome) 25 8q24 deletion (Langer-Giedion syndrome) 26 Turnaround time 27 Specimen and shipping requirements 27 2 Noninvasive prenatal testing with targeted genome counting Sema4’s Noninvasive Prenatal Testing (NIPT)- Targeted Genome Counting analyzes genetic information of cell-free DNA (cfDNA) through a simple maternal blood draw to determine the risk for common aneuploidies, sex chromosomal abnormalities, and microdeletions, in addition to fetal gender, as early as nine weeks gestation. The test uses paired-end next-generation sequencing technology to provide higher depth across targeted regions. It also uses a laboratory-specific statistical model to help reduce false positive and false negative rates. The test can be offered to all women with singleton, twins and triplet pregnancies, including egg donor. The conditions offered are shown in below tables. For multiple gestation pregnancies, screening of three conditions -
Fragile X Syndrome
216 Current Genomics, 2011, 12, 216-224 Fragile X Syndrome Yingratana McLennan1, Jonathan Polussa1, Flora Tassone1,2 and Randi Hagerman*,1,3 1Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California Davis Health System, Sacramento, California, USA 2Department of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Davis, California, USA 3Department of Pediatrics, University of California Davis Health System, Sacramento, California, USA Abstract: Recent data from a national survey highlighted a significant difference in obesity rates in young fragile X males (31%) compared to age matched controls (18%). Fragile X syndrome (FXS) is the most common cause of intellectual disability in males and the most common single gene cause of autism. This X-linked disorder is caused by an expansion of a trinucleotide CGG repeat (>200) on the promotor region of the fragile X mental retardation 1 gene (FMR1). As a result, the promotor region often becomes methylated which leads to a deficiency or absence of the FMR1 protein (FMRP). Common characteristics of FXS include mild to severe cognitive impairments in males but less severe cognitive impairment in females. Physical features of FXS include an elongated face, prominent ears, and post-pubertal macroorchidism. Severe obesity in full mutation males is often associated with the Prader-Willi phenotype (PWP) which includes hyperphagia, lack of satiation after meals, and hypogonadism or delayed puberty; however, there is no deletion at 15q11-q13 nor uniparental maternal disomy. Herein, we discuss the molecular mechanisms leading to FXS and the Prader-Willi phenotype with an emphasis on mouse FMR1 knockout studies that have shown the reversal of weight increase through mGluR antagonists. -
Inheriting Genetic Conditions
Help Me Understand Genetics Inheriting Genetic Conditions Reprinted from MedlinePlus Genetics U.S. National Library of Medicine National Institutes of Health Department of Health & Human Services Table of Contents 1 What does it mean if a disorder seems to run in my family? 1 2 Why is it important to know my family health history? 4 3 What are the different ways a genetic condition can be inherited? 6 4 If a genetic disorder runs in my family, what are the chances that my children will have the condition? 15 5 What are reduced penetrance and variable expressivity? 18 6 What do geneticists mean by anticipation? 19 7 What are genomic imprinting and uniparental disomy? 20 8 Are chromosomal disorders inherited? 22 9 Why are some genetic conditions more common in particular ethnic groups? 23 10 What is heritability? 24 Reprinted from MedlinePlus Genetics (https://medlineplus.gov/genetics/) i Inheriting Genetic Conditions 1 What does it mean if a disorder seems to run in my family? A particular disorder might be described as “running in a family” if more than one person in the family has the condition. Some disorders that affect multiple family members are caused by gene variants (also known as mutations), which can be inherited (passed down from parent to child). Other conditions that appear to run in families are not causedby variants in single genes. Instead, environmental factors such as dietary habits, pollutants, or a combination of genetic and environmental factors are responsible for these disorders. It is not always easy to determine whether a condition in a family is inherited. -
Classic and Molecular Cytogenetic Analyses Reveal Chromosomal Gains and Losses Correlated with Survival in Head and Neck Cancer Patients
Vol. 11, 621–631, January 15, 2005 Clinical Cancer Research 621 Classic and Molecular Cytogenetic Analyses Reveal Chromosomal Gains and Losses Correlated with Survival in Head and Neck Cancer Patients Na´dia Aparecida Be´rgamo,1 that acquisition of monosomy 17 was a significant (P = Luciana Caricati da Silva Veiga,1 0.0012) factor for patients with a previous family history of Patricia Pintor dos Reis,4 Ineˆs Nobuko Nishimoto,3 cancer. Conclusions: The significant associations found in this Jose´ Magrin,3 Luiz Paulo Kowalski,3 4 2 study emphasize that alterations of distinct regions of the Jeremy A. Squire, and Sı´lvia Regina Rogatto genome may be genetic biomarkers for a poor prognosis. 1Department of Genetics, Institute of Biosciences and 2NeoGene Losses of chromosomes 17 and 22 can be associated with Laboratory, Department of Urology, Faculty of Medicine, Sa˜o Paulo a family history of cancer. State University; 3Department of Head and Neck Surgery and Otorhinolaryngology, AC Camargo Hospital, Sa˜o Paulo, Brazil and 4Department of Cellular and Molecular Biology, Princess Margaret INTRODUCTION Hospital, Ontario Cancer Institute, University of Toronto, Toronto, Carcinomas of the head and neck represent the sixth most Ontario, Canada frequent cancer worldwide and f90% to 95% are squamous cell carcinomas. Tobacco and alcohol consumption are the ABSTRACT most important nongenetic risk factors associated with the Purpose: Genetic biomarkers of head and neck tumors development of head and neck squamous cell carcinomas could be useful for distinguishing among patients with (HNSCC; ref. 1). Estimated age-standardized rates per similar clinical and histopathologic characteristics but 100,000 for 1990 showed 12.8 men and 3.7 women of oral having differential probabilities of survival. -
Profiling Cellular Processes in Adipose Tissue During Weight Loss Using Time Series Gene Expression
G C A T T A C G G C A T genes Article Profiling Cellular Processes in Adipose Tissue during Weight Loss Using Time Series Gene Expression Samar H. K. Tareen 1,* , Michiel E. Adriaens 1,* , Ilja C. W. Arts 1,2, Theo M. de Kok 1,3, Roel G. Vink 4, Nadia J. T. Roumans 4, Marleen A. van Baak 4, Edwin C. M. Mariman 4, Chris T. Evelo 1,5,* and Martina Kutmon 1,5,* 1 Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, 6211ER Maastricht, The Netherlands; [email protected] (I.C.W.A.); [email protected] (T.M.d.K.) 2 Department of Epidemiology, CARIM School for Cardiovascular Diseases, Maastricht University, 6211ER Maastricht, The Netherlands 3 Department of Toxicogenomics, GROW School of Oncology and Developmental Biology, Maastricht University, 6211ER Maastricht, The Netherlands 4 Department of Human Biology, NUTRIM Research School, Maastricht University, 6211ER Maastricht, The Netherlands; [email protected] (R.G.V.); [email protected] (N.J.T.R.); [email protected] (M.A.v.B.); [email protected] (E.C.M.M.) 5 Department of Bioinformatics—BiGCaT, NUTRIM Research School, Maastricht University, 6211ER Maastricht, The Netherlands * Correspondence: [email protected] (S.H.K.T.); [email protected] (M.E.A.); [email protected] (C.T.E.); [email protected] (M.K.) Received: 28 September 2018; Accepted: 22 October 2018; Published: 29 October 2018 Abstract: Obesity is a global epidemic identified as a major risk factor for multiple chronic diseases and, consequently, diet-induced weight loss is used to counter obesity. -
Abstracts from the 50Th European Society of Human Genetics Conference: Electronic Posters
European Journal of Human Genetics (2019) 26:820–1023 https://doi.org/10.1038/s41431-018-0248-6 ABSTRACT Abstracts from the 50th European Society of Human Genetics Conference: Electronic Posters Copenhagen, Denmark, May 27–30, 2017 Published online: 1 October 2018 © European Society of Human Genetics 2018 The ESHG 2017 marks the 50th Anniversary of the first ESHG Conference which took place in Copenhagen in 1967. Additional information about the event may be found on the conference website: https://2017.eshg.org/ Sponsorship: Publication of this supplement is sponsored by the European Society of Human Genetics. All authors were asked to address any potential bias in their abstract and to declare any competing financial interests. These disclosures are listed at the end of each abstract. Contributions of up to EUR 10 000 (ten thousand euros, or equivalent value in kind) per year per company are considered "modest". Contributions above EUR 10 000 per year are considered "significant". 1234567890();,: 1234567890();,: E-P01 Reproductive Genetics/Prenatal and fetal echocardiography. The molecular karyotyping Genetics revealed a gain in 8p11.22-p23.1 region with a size of 27.2 Mb containing 122 OMIM gene and a loss in 8p23.1- E-P01.02 p23.3 region with a size of 6.8 Mb containing 15 OMIM Prenatal diagnosis in a case of 8p inverted gene. The findings were correlated with 8p inverted dupli- duplication deletion syndrome cation deletion syndrome. Conclusion: Our study empha- sizes the importance of using additional molecular O¨. Kırbıyık, K. M. Erdog˘an, O¨.O¨zer Kaya, B. O¨zyılmaz, cytogenetic methods in clinical follow-up of complex Y. -
Mosaic Genome-Wide Maternal Isodiploidy: an Extreme Form Of
Bens et al. Clinical Epigenetics (2017) 9:111 DOI 10.1186/s13148-017-0410-y RESEARCH Open Access Mosaic genome-wide maternal isodiploidy: an extreme form of imprinting disorder presenting as prenatal diagnostic challenge Susanne Bens1*, Manuel Luedeke1, Tanja Richter1, Melanie Graf1, Julia Kolarova1, Gotthold Barbi1, Krisztian Lato2, Thomas F. Barth3 and Reiner Siebert1 Abstract Background: Uniparental disomy of certain chromosomes are associated with a group of well-known genetic syndromes referred to as imprinting disorders. However, the extreme form of uniparental disomy affecting the whole genome is usually not compatible with life, with the exception of very rare cases of patients with mosaic genome-wide uniparental disomy reported in the literature. Results: We here report on a fetus with intrauterine growth retardation and malformations observed on prenatal ultrasound leading to invasive prenatal testing. By cytogenetic (conventional karyotyping), molecular cytogenetic (QF-PCR, FISH, array), and methylation (MS-MLPA) analyses of amniotic fluid, we detected mosaicism for one cell line with genome-wide maternal uniparental disomy and a second diploid cell line of biparental inheritance with trisomy X due to paternal isodisomy X. As expected for this constellation, we observed DNA methylation changes at all imprinted loci investigated. Conclusions: This report adds new information on phenotypic outcome of mosaic genome-wide maternal uniparental disomy leading to an extreme form of multilocus imprinting disturbance. Moreover, the findings highlight the technical challenges of detecting these rare chromosome disorders prenatally. Keywords: Genome-wide maternal uniparental disomy, Imprinting, Prenatal diagnostics, DNA methylation, Multilocus imprinting disturbances Background of isodisomy include unmasking of recessive diseases by Uniparental disomy (UPD) refers to the constellation of two transmitting two affected gene copies from one heterozy- identical (isodisomy) or homologous (heterodisomy) chro- gous parent carrier [2]. -
Cytogenetics, Chromosomal Genetics
Cytogenetics Chromosomal Genetics Sophie Dahoun Service de Génétique Médicale, HUG Geneva, Switzerland [email protected] Training Course in Sexual and Reproductive Health Research Geneva 2010 Cytogenetics is the branch of genetics that correlates the structure, number, and behaviour of chromosomes with heredity and diseases Conventional cytogenetics Molecular cytogenetics Molecular Biology I. Karyotype Definition Chromosomal Banding Resolution limits Nomenclature The metaphasic chromosome telomeres p arm q arm G-banded Human Karyotype Tjio & Levan 1956 Karyotype: The characterization of the chromosomal complement of an individual's cell, including number, form, and size of the chromosomes. A photomicrograph of chromosomes arranged according to a standard classification. A chromosome banding pattern is comprised of alternating light and dark stripes, or bands, that appear along its length after being stained with a dye. A unique banding pattern is used to identify each chromosome Chromosome banding techniques and staining Giemsa has become the most commonly used stain in cytogenetic analysis. Most G-banding techniques require pretreating the chromosomes with a proteolytic enzyme such as trypsin. G- banding preferentially stains the regions of DNA that are rich in adenine and thymine. R-banding involves pretreating cells with a hot salt solution that denatures DNA that is rich in adenine and thymine. The chromosomes are then stained with Giemsa. C-banding stains areas of heterochromatin, which are tightly packed and contain